Pseudomonas Infections
📧 Sign up to get email alerts when something new happens for Pseudomonas Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa
This clinical trial update concerns antimicrobial therapy for difficult-to-treat Pseudomonas aeruginosa infections. The study is currently r…
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa [Phase 3]
A Phase 3 trial evaluating tobramycin for bronchiectasis patients colonized with Pseudomonas aeruginosa is underway, with status not specifi…
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections
The update describes clinical outcomes with ceftolozane-tazobactam for multidrug-resistant Pseudomonas infections from a clinical trial, tho…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Phase I Study of Colistin Methanesulfonate Sodium [Phase 1]
Phase I trial of Colistin methanesulfonate sodium for Pseudomonas infections has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036) [NA]
A completed NIH-supported clinical trial update focusing on optimizing colistin dosing for infections resistant to all other antibiotics.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2008-02-22Clinical Trial Update: Lcr35 / ICU / P. Aeruginosa [NA]
A clinical trial evaluating Lcr35 in ICU patients with Pseudomonas infections was terminated.